FDA approves Ocrevus for children with multiple sclerosis, expanding treatment options.
FDA approves Ocrevus for children with multiple sclerosis, expanding treatment options.
Community donations enable pediatric cancer researchers to achieve a major breakthrough offering hope to young patients.
A $1 million grant will accelerate breakthrough research for a rare pediatric cancer.
A child with rare genetic disease receives newly approved FDA treatment, offering hope for similar patients.
A promising new pediatric diabetes drug successfully completed clinical trials, offering hope for young patients.
Event encourages rural youth to pursue medical careers and improve healthcare access.
UNC pharmacy researchers are making progress toward breakthrough treatments for pediatric brain cancer.
Teddy Bear Clinic gives children hands-on medical experience, reducing healthcare anxiety through play.
A mother's urgent advocacy for FDA approval of a new drug offers hope for children suffering from terminal Hunter Syndrome.
Parents advocate for expedited access to life-saving medications for children with rare genetic diseases.
FDA approves innovative new delivery method for spinal muscular atrophy gene therapy, improving accessibility for patients.